Standout Papers

Dabigatran versus Warfarin in Patients with Atrial Fibrillati... 2000 2026 2008 2017 7.8k
  1. Dabigatran versus Warfarin in Patients with Atrial Fibrillation (2009)
    Stuart J. Connolly, Michael D. Ezekowitz et al. New England Journal of Medicine
  2. Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation (2009)
    Stuart J. Connolly New England Journal of Medicine
  3. Subclinical Atrial Fibrillation and the Risk of Stroke (2012)
    Jeff S. Healey, Stuart J. Connolly et al. New England Journal of Medicine
  4. Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure (2010)
    Anthony Tang, George A. Wells et al. New England Journal of Medicine
  5. Canadian Implantable Defibrillator Study (CIDS) (2000)
    Stuart J. Connolly, Michael Gent et al. Circulation
  6. Dabigatran versus Warfarin in Patients with Mechanical Heart Valves (2013)
    John W. Eikelboom, Stuart J. Connolly et al. New England Journal of Medicine
  7. Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial Infarction (2004)
    Stefan H. Hohnloser, Karl Heinz Kuck et al. New England Journal of Medicine
  8. Canadian atrial fibrillation anticoaguiation (CAFA) study (1991)
    Stuart J. Connolly, Andreas Laupacis et al. Journal of the American College of Cardiology
  9. Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation (2011)
    John W. Eikelboom, Lars Wallentin et al. Circulation
  10. Amiodarone to Prevent Recurrence of Atrial Fibrillation (2000)
    Denis‐Claude Roy, Mario Talajic et al. New England Journal of Medicine
  11. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial (2010)
    Lars Wallentin, Salim Yusuf et al. The Lancet
  12. Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity (2015)
    Deborah Siegal, John T. Curnutte et al. New England Journal of Medicine
  13. Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation (2009)
    Stefan H. Hohnloser, Harry J.G.M. Crijns et al. New England Journal of Medicine
  14. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome (1983)
    Christian Guilleminault, Stuart J. Connolly et al. The American Journal of Cardiology
  15. Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range (2008)
    Stuart J. Connolly, Janice Pogue et al. Circulation
  16. The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients (2013)
    Paul Reilly, Thorsten Lehr et al. Journal of the American College of Cardiology
  17. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT (1997)
    John A. Cairns, Stuart J. Connolly et al. The Lancet
  18. Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events (2014)
    Michela Brambatti, Stuart J. Connolly et al. Circulation
  19. Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2) (2014)
    Carlos A. Morillo, Atul Verma et al. JAMA
  20. CYCLICAL VARIATION OF THE HEART RATE IN SLEEP APNOEA SYNDROME (1984)
    Christian Guilleminault, Roger A. Winkle et al. The Lancet
  21. Embolic Stroke of Undetermined Source (2017)
    Robert G. Hart, Luciana Catanese et al. Stroke
  22. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT (2017)
    Isabelle C. Van Gelder, Jeff S. Healey et al. European Heart Journal
  23. 2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation (2014)
    Atul Verma, John A. Cairns et al. Canadian Journal of Cardiology
  24. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study (2016)
    Ziad Hijazi, Jonas Oldgren et al. The Lancet
  25. Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease (2018)
    Sonia S. Anand, François Caron et al. Journal of the American College of Cardiology
  26. Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials (2023)
    William F. McIntyre, Alexander P. Benz et al. Circulation

Immediate Impact

165 standout
Sub-graph 1 of 12

Citing Papers

Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation
2020 Standout
Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation
2020 Standout
225 intermediate papers

Works of Stuart J. Connolly being referenced

Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
and 96 more

Author Peers

Author Last Decade Papers Cites
Stuart J. Connolly 42494 11551 4572 5330 470 47.1k
Michael D. Ezekowitz 40498 13070 3830 7523 264 46.7k
Kenneth W. Mahaffey 31634 10144 12747 3795 646 46.4k
Jonathan L. Halperin 28140 9327 3136 5980 296 33.9k
Elaine M. Hylek 23759 10794 2612 4395 252 30.2k
John W. Eikelboom 34233 18050 9081 5503 653 46.1k
Harry J.G.M. Crijns 35250 4113 3255 3035 595 41.1k
Lars Wallentin 47953 14817 13944 5432 733 57.5k
Basil S. Lewis 18835 6722 6079 2732 274 24.4k
Robert M. Califf 23485 6328 7604 2884 305 29.7k
Adrian F. Hernandez 25386 2921 6082 7584 884 40.6k

All Works

Loading papers...

Rankless by CCL
2026